Schedule 13G ownership disclosure

HORIZON THERAPEUTICS PUB L

Security class unavailable · CUSIP: G46188101

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
19,920,258
Percent of class
9.0300%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-21-018295
Form type
SC 13G/A
Filer
Horizon Therapeutics Public Ltd Co
CIK
CIK 1492426
Filed
Feb 10, 2021
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub